Antimicrobial Photodynamic Therapy as an Adjunct for Management of Deep Caries Lesions

NCT ID: NCT05236205

Last Updated: 2022-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-30

Study Completion Date

2022-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alternatively to conventional treatments, chemo-mechanical caries removal agents can be used. A modality of treatment that has been increasing in dentistry is antimicrobial photodynamic therapy (aPDT). Bixa orellana, is being researched for application in aPDT. This protocol aims to determine the effectiveness of aPDT with Bixa orellana extract in deep caries lesions. Methods and analysis: A total of 160 teeth with deep occlusal dental caries will be selected and divided in 3 groups: G1 - control group (Caries removal with a lowspeed drill); G2 - Partial Caries Removal with Papacarie; G3 - Partial Caries Removal with Papacarie and application Bixa orellana extract (20%); G4 - Partial Caries Removal with Papacarie and application Bixa orellana extract (20%) with LED (aPDT). After treatment, all the teeth will be restored with glass ionomer cement and followed up clinically and radiographically, with evaluations at immediately, 1 week, 1, 3, 6, and 12 months. Dentin samples before and after treatment will be analyzed microbiologically. The data will be submitted to descriptive statistical analysis of the association between the categorical variables using the chi-square test and Fisher exact text. The Student t test and analysis of variance will be used for the comparison of mean signs and symptoms of reversible pulpitis. Pearson correlation coefficients will be calculated for the analysis of correlations among the continuous variables.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The clinical evaluations of the carious tissue removal, as well as the microbiological and radiographic analyses, will be performed by examiners blinded to the treatments performed on each tooth.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

This group will receive the treatment of caries removal with a lowspeed drill (conventional treatment).

Group Type EXPERIMENTAL

Caries removal with a lowspeed drill

Intervention Type PROCEDURE

1. Initial periapical and interproximal radiographs;
2. Prophylaxis with toothbrush and fluoride toothpaste;
3. Relative isolation with lip bumper, cotton roll, and aspirator;
4. Microbiological sampling with ear curette for standardization of volume of carious tissue;
5. Removal of carious dentin with carbide burs and manual instruments;
6. Additional microbiological sampling;
7. Clinical inspection of texture of remaining dentin with an exploratory probe;
8. Restoration with glass ionomer cement (Ketac Molar Easy Mix - 3M ESPE);
9. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months.

Papacarie

In this group, partial caries removal with Papacarie will be performed.

Group Type EXPERIMENTAL

Partial removal of carious tissue with the administration of Papacarie™

Intervention Type PROCEDURE

1. Initial radiographs;
2. Relative isolation;
3. Microbiological sample with otoscope curette to standardize volume of carious tissue;
4. Application of Papacarie™ for 5 m inutes, removal of carious tissue around lateral walls of the cavity with noncutting curette and no removal of carious tissue on pulp floor;
5. Second microbiological sample of remaining dentin with curette;
6. Clinical evaluation by inspection of texture of remaining dentin with exploratory probe;
7. Restoration with glass ionomer cement;
8. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months after treatment.

Papacarie and Bixa orellana extract

In this group, partial caries removal with Papacarie and the application of Bixa orellana extract (20%) will be performed.

Group Type EXPERIMENTAL

Partial removal of carious tissue with the administration of Papacarie™ and application of Bixa Orellana extract (20%)

Intervention Type PROCEDURE

1. Initial radiographs;
2. Relative isolation;
3. Microbiological sample with otoscope curette to standardize volume of carious tissue;
4. Application of Papacarie™ with Bixa Orellana extract (20%) for 5 minutes, removal of carious tissue around lateral walls of the cavity with noncutting curette;
5. Irradiation of dental tissue for 1 minute on a single point;
6. Second microbiological sample of remaining dentin with curette;
7. Clinical evaluation by inspection of texture of remaining dentin with exploratory probe;
8. Restoration with glass ionomer cement;
9. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months after treatment.

Partial removal with aPDT

In this group, partial removal of the carious tissue will be performed, with Papacarie and the application of Bixa orellana extract (20%) with blue LED (aPDT).

Group Type EXPERIMENTAL

Partial removal of carious tissue with the administration of Papacarie™, application of Bixa Orellana extract (20%) and LED (aPDT)

Intervention Type PROCEDURE

1. Initial radiographs;
2. Relative isolation;
3. Microbiological sample with otoscope curette to standardize volume of carious tissue;
4. Application of Papacarie™ with Bixa Orellana extract (20%) for 5 minutes and the blue light-emitting diode (LED) irradiation with 440-480 nm. Removal of carious tissue around lateral walls of the cavity with noncutting curette;
5. Irradiation of dental tissue for 1 minute on a single point;
6. Second microbiological sample of remaining dentin with curette;
7. Clinical evaluation by inspection of texture of remaining dentin with exploratory probe;
8. Restoration with glass ionomer cement (Ketac Molar EasyMIx 3M ESPE);
9. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months after treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caries removal with a lowspeed drill

1. Initial periapical and interproximal radiographs;
2. Prophylaxis with toothbrush and fluoride toothpaste;
3. Relative isolation with lip bumper, cotton roll, and aspirator;
4. Microbiological sampling with ear curette for standardization of volume of carious tissue;
5. Removal of carious dentin with carbide burs and manual instruments;
6. Additional microbiological sampling;
7. Clinical inspection of texture of remaining dentin with an exploratory probe;
8. Restoration with glass ionomer cement (Ketac Molar Easy Mix - 3M ESPE);
9. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months.

Intervention Type PROCEDURE

Partial removal of carious tissue with the administration of Papacarie™

1. Initial radiographs;
2. Relative isolation;
3. Microbiological sample with otoscope curette to standardize volume of carious tissue;
4. Application of Papacarie™ for 5 m inutes, removal of carious tissue around lateral walls of the cavity with noncutting curette and no removal of carious tissue on pulp floor;
5. Second microbiological sample of remaining dentin with curette;
6. Clinical evaluation by inspection of texture of remaining dentin with exploratory probe;
7. Restoration with glass ionomer cement;
8. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months after treatment.

Intervention Type PROCEDURE

Partial removal of carious tissue with the administration of Papacarie™ and application of Bixa Orellana extract (20%)

1. Initial radiographs;
2. Relative isolation;
3. Microbiological sample with otoscope curette to standardize volume of carious tissue;
4. Application of Papacarie™ with Bixa Orellana extract (20%) for 5 minutes, removal of carious tissue around lateral walls of the cavity with noncutting curette;
5. Irradiation of dental tissue for 1 minute on a single point;
6. Second microbiological sample of remaining dentin with curette;
7. Clinical evaluation by inspection of texture of remaining dentin with exploratory probe;
8. Restoration with glass ionomer cement;
9. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months after treatment.

Intervention Type PROCEDURE

Partial removal of carious tissue with the administration of Papacarie™, application of Bixa Orellana extract (20%) and LED (aPDT)

1. Initial radiographs;
2. Relative isolation;
3. Microbiological sample with otoscope curette to standardize volume of carious tissue;
4. Application of Papacarie™ with Bixa Orellana extract (20%) for 5 minutes and the blue light-emitting diode (LED) irradiation with 440-480 nm. Removal of carious tissue around lateral walls of the cavity with noncutting curette;
5. Irradiation of dental tissue for 1 minute on a single point;
6. Second microbiological sample of remaining dentin with curette;
7. Clinical evaluation by inspection of texture of remaining dentin with exploratory probe;
8. Restoration with glass ionomer cement (Ketac Molar EasyMIx 3M ESPE);
9. Clinical and radiographic follow-up immediately, 1 week, 1, 3, 6, and 12 months after treatment.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adequate health with no systemic conditions;
* Adequate cooperation;
* Clinically presenting at least 1 permanent molar with an acute, active caries on the dentin not surpassing 2/3 and only involving the occlusal face, with direct view and access as well as no clinical or radiographic signs of pulp involvement.

Exclusion Criteria

* Systemic adverse health condition;
* Uncooperative behavior;
* Class II, III, IV, or V carious lesion based on Black classification;
* Clinically: caries involving enamel, deficient restorations, small carious lesions on dentin with no access for manual scalers, hidden caries, sign or symptom of pulp involvement, clinical impossibility of restoration;
* Radiographically: evidence of pulp involvement, carious lesion extending beyond 2/3 of dentin.
Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nove de Julho

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sandra Kalil Bussadori

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Martins LFB, de Sena LR, de Paula DM, Feitosa VP, Horliana ACRT, Fernandes KPS, Mesquita-Ferrari RA, Motta LJ, Goncalves MLL, Bussadori SK. Investigation on the effect of antimicrobial photodynamic therapy as an adjunct for management of deep caries lesions-study protocol for a randomized, parallel groups, controlled clinical trial. Trials. 2023 Mar 4;24(1):165. doi: 10.1186/s13063-023-07181-8.

Reference Type DERIVED
PMID: 36870982 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UrucumCaries

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.